Somerset, Wiltshire, Avon, and Gloucestershire Cancer Alliance Lung Cancer Screening Managed Service

Tender description

Bristol NHS Foundation Trust (BFT) intends to commence a procurement exercise, potential as early as November 2026, to secure a provider capable of delivering the provision of a fully managed Lung Cancer Screening (LCS) service, previously known as the Targeted Lung Health (TLHC), across the Somerset, Wiltshire, Avon and Gloucestershire (SWAG) regional programme. Lot 1: The proposed contract term is anticipated to be 36 months, with the option to extend for up to two further periods of 12 months each, resulting in a maximum potential contract duration of 60 months. The procurement is expected to establish an end-to-end managed service, with the appointed provider responsible for the delivery of services including, but not limited to: • Clinical and diagnostic services, including the provision of appropriately qualified workforce and equipped mobile units. • IT systems and data management services. • Programme management services, including logistics, stakeholder communications, and continuous service development. Whilst the final service model remains subject to further development, the anticipated pathway is expected to include: 1. Identification of the eligible population cohort. 2. Appointment booking and scheduling. 3. Lung Health Check assessment. 4. Face-to-face clinical review and Low-Dose CT (LDCT) scanning. 5. Reporting and clinical assessment of results. 6. Multidisciplinary screening review meetings. 7. Communication of results, including rebooking where applicable; and 8. Follow-up, surveillance and recall activities. BFT is currently evaluating potential procurement routes under the Provider Selection Regime (PSR), including: • A Competitive Process conducted through the open market; or • A further competition via the NHS Shared Business Services (SBS) Clinical Managed Services Framework (SBS10251) BFT is seeking to implement the service within a challenging timeframe to support delivery of the SWAG Lung Cancer Screening Programme. Interested providers should note the anticipated accelerated procurement and mobilisation requirements and ensure they have sufficient capacity and resources to participate. The current indicative timetable is as follows: Tender Publication 02-Nov-26 Bid Submission Deadline 30-Nov-26 Contract Award 26-Jan-27 Contract Mobilisation 01-Feb-27 Service Commencement 01-Ap-27 Interested providers are invited to express their interest in this opportunity and provide feedback on the proposed procurement approach by responding to this notice using the contact details provided. BFT particularly welcomes feedback on the proposed procurement route, timeline and any other relevant considerations that may assist in informing the development of the procurement strategy. Organisations interested in this and future opportunities with the Trust are encouraged to register, free of charge, on the SAP Business Network Discovery Portal: SAP Business Network Discovery (ariba.com). This notice is issued for preliminary market engagement purposes only. It does not constitute a call for competition, commence a formal procurement process, or commit BFT to undertake a procurement exercise or award a contract. Any future procurement opportunity will be advertised separately in accordance with the applicable requirements of the Provider Selection Regime. The Trust will review and consider all feedback submitted but reserves the right to amend the structure, scope and procurement strategy described within this Notice prior to issuing the formal tender. Additional information: IMPORTANT MARKET NOTICE - REPLACEMENT OF PREVIOUS NOTICE Purpose: This F0 notice is being issued to announce a procurement opportunity for healthcare services under the Health Care Services (Provider Selection Regime) Regulations 2023. Correction Details: This notice directly replaces the previously published notice under reference 2026/S 000-095472, which was incorrectly classified as a UK2 notice. Legal Framework Clarification: For the avoidance of doubt, this procurement is governed strictly by the Provider Selection Regime (PSR). The provisions of the Procurement Act 2023 do not apply to this healthcare services requirement. Action Required by Suppliers: Suppliers who previously expressed interest in this opportunity via the UK2 2026/S 000-095472 need not respond to this F0 notice. Please disregard the previous UK2 publication, as it has been administratively withdrawn/superseded to correct this procedural error. For the avoidance of doubt, the true audit trail sits with the aforementioned UK2 notice.